Cognitive-Behavioral Therapy for the Treatment of Depression and Adherence in Patients With Type 1 Diabetes: Pilot Data and Feasibility
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Depression is one of the most common psychological problems affecting individuals with type 1 diabetes, and it is associated with treatment nonadherence and worse clinical outcomes. The research on treating depression or nonadherence in adults with type 1 diabetes is limited. We adapted an evidence-supported treatment, individual cognitive-behavioral therapy for adherence and depression (CBT-AD), for type 1 diabetes and examined its feasibility, acceptability, and potential for an effect. METHOD: The pilot study included 9 patients with a DSM-IV diagnosis of major depression, dysthymia, or residual depressive symptoms despite treatment with an antidepressant; a diagnosis of type 1 diabetes per patient self-report; and a glycosylated hemoglobin A1c (HbA1c) level of 8.0% or greater. Patients were referred by their diabetes care providers to a behavioral medicine specialty setting and received 10 to 12 sessions of CBT-AD. Main outcome measures included percent of eligible participants who enrolled in the study, session attendance, independently-rated Montgomery-Asberg Depression Rating Scale (MADRS) score, self-reported adherence to diabetes care activities, and adherence to self-monitoring of blood glucose levels. Data were collected from June 27, 2008, through March 31, 2010. RESULTS: There was a clinically meaningful decrease in depression severity (mean [SD] MADRS score decrease from 26.0 [4.73] to 12.3 [7.37], Cohen d = 2.90), demonstrated improvements in diabetes self-care (increase in blood glucose monitoring from 65.0 [26.72] to 82.7 [22.75], Cohen d = -0.66, and a difference in self-reported percent insulin doses in the past 2 weeks from 77.1 [29.84] to 87.1 [23.6], Cohen d = -0.34), and possible improvement in glycemic control (decrease in HbA1c levels from 9.6 [1.32] to 9.0 [1.04], Cohen d = 0.45). CONCLUSIONS: These preliminary results provide evidence for the acceptability, feasibility, and potential utility of CBT-AD for patients with type 1 diabetes and depression. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT01527981.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Standards of Medical Care in Diabetes—2009
American Diabetes Association (2009) · Diabetes Care · doi:10.2337/dc09-s013 · Cited by 2,167
Depression and poor glycemic control: a meta-analytic review of the literature.
Lustman, P. J., Anderson, R. J., Freedland, K. E., de Groot, M., Carney, R. M., & Clouse, R. E. (2000) · Diabetes Care · doi:10.2337/diacare.23.7.934 · Cited by 1,854
Association of depression and diabetes complications: a meta-analysis
de Groot, M., Anderson, R., Freedland, K. E., Clouse, R. E., & Lustman, P. J. (2001) · Psychosomatic Medicine · doi:10.1097/00006842-200107000-00015 · Cited by 1,799
Ciechanowski, P. S., Katon, W. J., Russo, J. E., & Hirsch, I. B. (2003) · General Hospital Psychiatry · doi:10.1016/s0163-8343(03)00055-0 · Cited by 428
Optimal recall period and response task for self-reported HIV medication adherence
Lu, M., Safren, S. A., Skolnik, P. R., Rogers, W. H., Coady, W., Hardy, H., & Wilson, I. B. (2008) · AIDS and Behavior · doi:10.1007/s10461-007-9261-4 · Cited by 361
Self-citationThe prevalence of co‐morbid depression in adults with Type 1 diabetes: systematic literature review
Barnard, K. D., Skinner, T. C., & Peveler, R. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01814.x · Cited by 350
Association between adherence and glycemic control in pediatric type 1 diabetes: a meta-analysis
Hood, K. K., Peterson, C. M., Rohan, J. M., & Drotar, D. (2009) · Pediatrics · doi:10.1542/peds.2009-0207 · Cited by 347
Depressive Symptoms and Mortality among Persons with and without Diabetes
Zhang, X. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi089 · Cited by 346
Safren, S. A., W. Otto, M., Worth, J. L., Salomon, E., Johnson, W., Mayer, K., & Boswell, S. (2001) · Behaviour Research and Therapy · doi:10.1016/s0005-7967(00)00091-7 · Cited by 327
A Review of Treating Depression in Diabetes: Emerging Findings
Markowitz, S. M., Gonzalez, J. S., Wilkinson, J. L., & Safren, S. A. (2011) · Psychosomatics · doi:10.1016/j.psym.2010.11.007 · Cited by 230
Self-citationChanges in depressive symptoms and glycemic control in diabetes mellitus
Georgiades, A., Zucker, N., Friedman, K. E., Mosunic, C. J., Applegate, K., Lane, J. D., Feinglos, M. N., & Surwit, R. S. (2007) · Psychosomatic Medicine · doi:10.1097/psy.0b013e318042588d · Cited by 99
Cognitive–Behavioral Therapy for Adherence and Depression (CBT-AD) in Type 2 Diabetes
Gonzalez, J. S., McCarl, L. A., Wexler, D. J., Cagliero, E., Delahanty, L., Soper, T. D., Goldman, V., Knauz, R., & Safren, S. A. (2010) · Journal of Cognitive Psychotherapy · doi:10.1891/0889-8391.24.4.329 · Cited by 55
Self-citation
Cited by
Eating disorders in adolescents with type 1 diabetes: challenges in diagnosis and treatment
Pinhas-Hamiel, O. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i3.517 · Cited by 150
Clifford, S., Perez-Nieves, M., Skalicky, A. M., Reaney, M., & Coyne, K. S. (2014) · Current Medical Research and Opinion · doi:10.1185/03007995.2014.884491 · Cited by 99
Adherence to insulin treatment in diabetes: can it be improved?糖尿病患者使用胰岛素治疗的依从性:它能够得到改善吗?
Doggrell, S. A., & Chan, V. (2015) · Journal of Diabetes · doi:10.1111/1753-0407.12212 · Cited by 29
Wang, Z.-D., Xia, Y.-F., Zhao, Y., & Chen, L.-M. (2017) · Bioscience Reports · doi:10.1042/bsr20160557 · Cited by 28
Metadata
- Authors
- Markowitz, S. M., Carper, M. M., Gonzalez, J. S., Delahanty, L. M., & Safren, S. A.
- Venue
- The Primary Care Companion For CNS Disorders
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2012-03-15
- Volume
- 14
- Issue
- 2
- ISSN
- 2155-7772 (ISSN-L)
- 2155-7780
- OpenAlex
- W2057783785
- Cited by
- 17
- References
- 12
- FWCI
- 2.30
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.